Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Circulating Tumor Cells (CTC) Global Market Report 2022: Growing Demand for Minimally Invasive Diagnostics Fuels Sector | ||
By: PR Newswire Association LLC. - 25 Nov 2022 | Back to overview list |
|
DUBLIN, Nov. 25, 2022 /PRNewswire/ -- The "Circulating Tumor Cells (CTC) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global circulating tumor cells (CTC) market size reached US$ 9.54 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 18.24 Billion by 2027, exhibiting a CAGR of 11.41% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. Furthermore, the growing demand for minimally invasive (MI) diagnostic procedures and widespread adoption of CTC-based liquid biopsy to enable rapid recovery and limit trauma are providing a considerable boost to the market growth. Apart from this, the introduction of nanotechnology to improve the sensitivity and efficiency of CTC isolation and detection is providing an impetus to market growth. Moreover, increasing utilization in medical research to develop cell culture models for drug screening, disease modeling, genome editing, and tumor immunity is creating a positive outlook for the market. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early cancer diagnosis is positively influencing the market growth. Other factors, including rapid advancements in biomedical imaging and bioengineering technology, extensive research and development (R&D) activities, and the rising demand for preventive medicine and companion diagnostics, are anticipated to drive the market growth.
Breakup by Application:
Breakup by Product:
Breakup by Specimen:
Breakup by End User:
Breakup by Region:
Key Topics Covered:
For more information about this report visit https://www.researchandmarkets.com/r/fccv05 Media Contact: Research and Markets
For E.S.T Office Hours Call +1-917-300-0470
U.S. Fax: 646-607-1907 Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/circulating-tumor-cells-ctc-global-market-report-2022-growing-demand-for-minimally-invasive-diagnostics-fuels-sector-301687152.html SOURCE Research and Markets |
||
|
||
Copyright 2022 PR Newswire Association LLC. | Back to overview list |